Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LEPROT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP4M1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CKAP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TWF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAFAH1B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PNPO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC12A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5S - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARFRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KANSL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NLE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIPEP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on